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Background: The human KALRN gene, which encodes a complex, multifunctional Rho GDP/GTP exchange factor,
has been linked to cardiovascular disease, psychiatric disorders and neurodegeneration. Examination of existing
Kalrn knockout mouse models has focused only on neuronal phenotypes. However, Kalirin was first identified
through its interaction with an enzyme involved in the synthesis and secretion of multiple bioactive peptides, and
studies in C.elegans revealed roles for its orthologue in neurosecretion.
Results: We used a broad array of tests to evaluate the effects of ablating a single exon in the spectrin repeat
region of Kalrn (KalSRKO/KO); transcripts encoding Kalrn isoforms containing only the second GEF domain can still be
produced from the single remaining functional Kalrn promoter. As expected, KalSRKO/KO mice showed a decrease in
anxiety-like behavior and a passive avoidance deficit. No changes were observed in prepulse inhibition of acoustic
startle or tests of depression-like behavior. Growth rate, parturition and pituitary secretion of growth hormone and
prolactin were deficient in the KalSRKO/KO mice. Based on the fact that a subset of Kalrn isoforms is expressed in
mouse skeletal muscle and the observation that muscle function in C.elegans requires its Kalrn orthologue, KalSRKO/KO
mice were evaluated in the rotarod and wire hang tests. KalSRKO/KO mice showed a profound decrease in
neuromuscular function, with deficits apparent in KalSR+/KO mice; these deficits were not as marked when loss of Kalrn
expression was restricted to the nervous system. Pre- and postsynaptic deficits in the neuromuscular junction were
observed, along with alterations in sarcomere length.
Conclusions: Many of the widespread and diverse deficits observed both within and outside of the nervous system
when expression of Kalrn is eliminated may reflect its role in secretory granule function and its expression outside of
the nervous system.
Keywords: Neuromuscular junction, Rotarod, Grip strength, Anxiety, Passive avoidance, Rho-GEFBackground
Mammalian genomes encode 60–70 Rho GDP/GTP ex-
change factors (Rho-GEFs) and a similar number of Rho
GTPase activating proteins (Rho-GAPs) to control the
activation and inactivation of ~20 Rho-family GTPases
[1]. The fact that mutations in individual Rho-GEFs are
associated with specific disease phenotypes indicates that
their functions are not redundant. For example, the
KALRN gene, which encodes proteins with two Rho-
GEF domains, has been associated with stroke [2], early* Correspondence: mains@uchc.edu
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reproduction in any medium, provided the oronset coronary artery disease [2-5], schizophrenia [6-9]
and adult attention deficit-hyperactivity disorder [10].
The mouse Kalrn gene includes multiple promoters and
several 30-untranslated regions which produce functionally
distinct isoforms in a tissue-specific and developmentally
regulated manner [11-13]. While some Rho-GEFs consist
of little more than the catalytic Dbl-homology (DH) do-
main followed by a pleckstrin homology (PH) domain,
Kalirin is a complex protein with multiple catalytic, pro-
tein/protein and protein/lipid interaction domains. The
longest isoform, Kalirin12, contains a lipid-binding Sec14
domain, nine spectrin-like repeats, two active Rho-GEF
domains, two SH3 domains, an Ig/FnIII domain, and a
kinase domain [14] (Figure 1). The most abundant iso-
form in the adult brain, Kalirin7, is almost exclusivelyl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Kalirin isoforms occur in many tissues. A. The major isoforms of Kalirin are diagramed. The qPCR primers used to quantify expression
of different regions of the Kalirin gene are indicated and antibody specificities are indicated. DH, Dbl homology; PH, Pleckstrin Homology; GEF1,
Guanine nucleotide exchange factor 1; SH3, Src homology domain; GEF2, Guanine nucleotide exchange factor 2; I, Immunoglobulin; F,
Fibronectin III; Kin, Kinase domain; red lines, unique 50- and 30-untranslated regions. B. Quantitative PCR was used to determine expression of
different regions of the Kalirin gene. Data are from individual preparations of RNA and cDNA from 4–8 mice for each tissue. The data were
averaged across assays, typically 4 assays per tissue. C. PolyA-containing RNA was prepared from adult rat cortex and liver, and hybridized with
[32P]-labeled probes for the GEF2 domain (1023 nt) or the region immediately 30 to the Kal9 stop codon (530 nt) [11]. Rps26 is ribosomal protein
S26, used as a loading control.
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plays an essential role in dendritic spine formation and
function [16-19]. Kalirin9 and Kalirin12 are more highly
expressed during nervous system development [20] and
are also expressed in heart, skeletal muscle and
endocrine tissue [20,21]. The single Kalrn orthologue in
C.elegans (UNC-73) and Drosophila (dTrio) plays essen-
tial roles both within and outside of the nervous system
[22,23].
Multiple promoters and 30-terminal exons in the Kalrn
gene preclude elimination of all isoforms through dele-
tion of any one region of the gene. A knockout mouse
for the most prevalent form of Kalirin in the adult brain,
Kalirin7, was generated by eliminating its unique 30-exon
(Kal7KO/KO) [13]. Kal7KO/KO mice have fewer dendritic
spines in selected brain regions and exhibit impaired
passive avoidance behavior, decreased anxiety-like be-
havior and accentuated locomotor sensitization to
repeated cocaine treatment [13,24]. Cahill et al. [25]
replaced Kalrn exons 27 and 28, which encode part of
the first GEF domain, with the neomycin resistance
gene, generating the KalGEF1KO/KO mouse [25].In this study, we flanked exon 13 in the spectrin re-
peat region with Lox-p sites (KalSRCKO/CKO); excision
of this region makes it impossible to regain an in-
reading-frame protein until exon 28. Global excision
yielded KalSRKO/KO mice while breeding of KalSRCKO/CKO
mice to mice expressing Cre-recombinase under control
of the Nestin promoter largely limited excision to the ner-
vous system (KalSRNesKO/NesKO). Based on our identifica-
tion of Kalirin through its interaction with a secretory
granule enzyme, the association of Kalrn with cardiovas-
cular and psychiatric disease and the roles of UNC-73 in
C.elegans, we searched for deficits caused by lack of Kalrn
within and outside of the nervous system.
Methods
Creation of global and nervous system specific Kalrn
knockout mice
The basic strategy for ablating exon 13 was the same as
for the Kalirin7-specific exon [13]. The Δ isoforms of
Kalirin start at exon 11; exon 13 was chosen because
exon 12 would have to be spliced to exon 28, in the mid-
dle of the GEF domain (Figure 2), to remain in the
Figure 2 Construction and verification of the Kalirin Exon 13 knockout (KalSRKO/KO). A. Diagram of the mouse Kalrn gene with exons
indicated as vertical bars; Exon 13 is shown in red. B. Detail of the knockout with PCR of DNA verifying the conditional and total knockouts.
C. Kalirin proteins are absent from KalSRKO/KO cortex. Kalirin was visualized using a Kalirin spectrin antibody; the band indicated by * was not
detected by Kal12 antisera and is therefore considered non-specific. The band indicated by # is thought to represent an aberrant, N-terminally
shortened product of the Δ-promoter. D. PSDs prepared from WT and KalSRKO/KO cortex were analyzed using Kal7-specific antibody; the product
that appears in the KalSRKO/KO PSDs is thought to represent the protein encoded by Exon 13-lacking transcripts initiated in the Δ-promoter.
E. Subcellular fractions probed using the Kal12-specific antibody showed the presence of Kalirin12 in the supernatant of a homogenate and in
the PSD fraction in WT, but not KO, extracts. Tubulin was used as a loading control. F. Quantitative PCR was used to demonstrate the absence of
transcripts containing Exon 13 in the KalSRKO mouse, while transcripts containing the Duet start were still detected.
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kb upstream (nucleotide 34254054 on chromosome 16,
mm9, July 2007) and 0.6 kb downstream of exon 13 (a
175 nt exon) (nucleotide 34251804). The strategy for re-
moving the neomycin resistance cassette using flipper
mice, breeding the conditional knockout mice into
C57Bl/6 (Jackson Laboratories) and eliminating exon 13
using Hprt-Cre females was as described [13]. Mice with
Lox-p sites flanking exon 13 are referred to as Kalirin
Spectrin Repeat Conditional Knockout (KalSRCKO) mice;
after Cre-mediated excision of exon 13, mice are re-
ferred to as Kalirin Spectrin Repeat Knockout (KalSRKO)
mice. Both strains have been bred more than 10 genera-
tions into the C57Bl/6 background. KalSRCKO/CKO and
KalSR+/CKO mice are of normal weight, reproduce welland have an unaltered distribution and level of Kalirin iso-
forms. KalSR+/KO mice were bred to obtain KalSRKO/KO
mice. KalSRCKO/CKO mice were crossed with C57Bl/6
mice expressing Cre recombinase under the control of the
Nestin promoter [B6.Cg-Tg(Nes-cre)1Kln/J], to yield
KalSRNesKO mice; expression of Cre recombinase outside
of the nervous and endocrine systems is minimal in this
mouse, with restricted expression in the vasculature
(http://jaxmice.jax.org/strain/003771.html).
Behavioral studies
Animals were group housed in the Center for Compara-
tive Medicine at the University of Connecticut Health
Center (UCHC) with a 12 h light/dark cycle (lights on
7:00 am - 7:00 pm). All behavioral experiments were
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ance with UCHC Institutional Animal Care and Use
Committee and National Institutes of Health guidelines.
Male and female littermates 2 to 4 months of age were
tested during the light phase. All animals were handled
daily for at least 4 d before behavioral testing to
minimize experimenter-induced stress. In addition, ani-
mals were allowed to habituate to the testing room for 1
h before testing. Animals were evaluated using several
behavioral tests; the less stressful tests preceded those
that were more stressful (open field→ elevated zero
maze→ tail suspension test → prepulse inhibition of
acoustic startle → rotarod→ grip test→ object recogni-
tion test→ passive avoidance test → restraint stress).
Tests were separated by 2 or more days, and the same
set of mice was used for all behavioral experiments.
Open field, elevated zero maze, passive avoidance, and
object recognition (male mice only) tests were per-
formed as described [13]. Briefly, open field behavior
was assessed by recording beam breaks for nine five-
minute time bins using a San Diego Instruments clear
Plexiglas chamber (38 cm × 38 cm). Naïve mice were
placed onto the elevated zero maze facing into the
closed area and the time spent in the open area (all four
feet) was monitored for 5 min. Passive avoidance behav-
ior was monitored using a San Diego Instruments 2-
chamber box; a 0.3 mA × 2 s scrambled footshock was
delivered at the end of the training period, when the
mouse was in the dark chamber. Novel object recogni-
tion was performed by placing the mouse into a clean
rat cage containing two Falcon tubes or two LEGOR
objects and recording the time spent exploring each ob-
ject over a three minute trial; the test was repeated the
next day using the same object plus a novel object. The
elevated zero maze and novel object recognition tests
were videotaped and scored by a blinded observer. Data
for male and female mice were analyzed separately;
when no difference was observed, data were pooled.Tail suspension
After taping the tail to a bent coat hanger, mice were
suspended 70 cm above the floor of the cage for 6 min.
Mice were videotaped and total time spent immobile
(defined as the complete cessation of movement) was
scored manually.Rotarod
Training sessions (3 days, 3 trials per day) were con-
ducted to acclimate the mice to the rotarod apparatus
(Med Associates, VT). Motor coordination was assessed
by measuring the length of time each mouse remained
on the rotating rod as it accelerated from 4 to 40 rpm
over a period of five min. On the 4th day, mice weretested in the same way three more times and the mean
was used as the measure of competence at this task.
Wire hang
Two parallel steel wires 8 cm long and separated by
2 cm were anchored to the middle of a cardboard
(40 cm × 22 cm); a 2 cm space separated the wires from
the cardboard enabling a mouse to grip the wires with
all four feet but not to climb onto the wires. The card-
board was suspended 30 cm above a rat cage containing
bedding to prevent injury. Mice were trained for 3 days;
on the fourth day, time spent suspended from the wires
was measured. On the testing day, each mouse under-
went 3 trials and the mean value was used to determine
wire hang time.
Acute restraint stress
When behavioral testing was finished, mice were
returned to their home cages for a week. Blood collected
via submandibular puncture two days prior to restraint
stress was used for measuring basal serum cortico-
sterone levels. Restraint stress was performed between
10:00 AM and noon by placing mice into ventilated 50-
ml plastic tubes for 15 minutes. Mice were then sacri-
ficed by decapitation; serum prepared from trunk blood
was stored at −80°C until assayed for corticosterone
(MP Diagnostics) and peptidylglycine α-hydroxylating
monoxygenase (PHM activity) [26].
Prepulse inhibition of the acoustic startle response
Male mice were subjected to acoustic startle testing and
measurement of prepulse inhibition (PPI) using two
identical startle chambers (San Diego Instruments) es-
sentially as described for rats [27]. Mice were placed into
a clear acrylic cylindrical chamber enclosed in a sound-
and vibration-attenuating cabinet equipped with a 5 W
bulb and ventilation fan. The chamber containing the
mouse sits on a base that contacts a piezoelectric accel-
erometer that detects the whole body startle response.
Output signals from the accelerometer are collected as
75 sequential 1 msec measurements starting at the onset
of the startling stimulus (120 dB, 40 msec). Mice were
allowed five min of acclimation prior to delivery of the
stimuli over a 70 dB white noise background. The first
and last six trials of the session consisted of the startle
stimulus alone (120 dB, 40 ms). Trials occurred in a ran-
dom order and consisted of 12 startle alone trials to cal-
culate % PPI and 12 prepulse + startle trials at each of 5
prepulse intensities (3, 6,12,15,18 dB), and 8 no stimulus
trials. Prepulse stimuli (20 ms) preceded startle stimuli
by 100 ms. Accelerometer signals were rectified and
digitized using SR-LAB (San Diego Instruments).
Chambers were calibrated daily and matched for sound
intensity [27].
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Blood pressure was measured using a non-invasive
CODA tail-cuff blood pressure occlusion system (Kent
Scientific). Measurements were taken in a quiet area
away from other activity. Conscious animals were intro-
duced into restraining chambers that were placed onto a
preheated pad maintained at 30°C; tail temperature was
measured using an infrared sensor and blood pressure
measurements were initiated when tail temperature
reached 30°C. Mice were trained for three days and on
the fourth day BP recordings were made. Each measure-
ment consisted of 5 acclimatization cycles followed by
15 blood pressure measurement cycles.Biochemical analyses
Analysis of DNA and RNA
DNA prepared from ear or tail snips [13] was used for
genotyping with the primers shown in Figure 2B: A,
TGTATGCCTTGGAAACAGGC; B, TGTTTTGCCATC
GGGAGGAT; C, TGCAAGGAACATCGGGCTTT. The
annealing temperature was 51°C (for 60 sec), elongation
was at 72°C for 30 sec, repeated 42 times. Tissue RNA
was prepared using Trizol as described [28]. Prepar-
ation of cDNA, quantitative polymerase chain reaction
(qPCR) primers and conditions were as described for
GAPDH, Kal7, Kal9, Kal12, Delta, and Kal-Spectrin
[28]. New primers used in this study are shown in
Table 1.Western blot analysis
Tissue fragments were solubilized in SDS lysis buffer
[29] with protease inhibitors added at 10 μg/ml (benza-
midine, leupeptin, soybean trypsin inhibitor, and aproti-
nin). After solubilization at 95°C, extracts were cleared
of insoluble debris by centrifugation at 14,000 × g. Solu-
bilized protein was quantified using a bicinchoninic acid
assay with bovine serum albumin as the standard
(Pierce). SDS-PAGE and immunoblotting with enhanced
chemiluminescence were performed as described [13].
Rabbit antiserum JH2582 (raised to recombinant Kalirin
spectrin repeats 4 to 7) and affinity-purified rabbit anti-
serum JH3225 (raised to the C-terminus of Kal12) [11]
were visualized using horseradish peroxidase-conjugated
anti-rabbit IgG.Table 1 Primers specific for Exon 13 and Duet
Kalirin domain Oligo name Sequence
Exon 13 Ex13-for CTCAGCGATGTC
Ex13-rev GAAGAGCTGTTT
Duet Duet-for CTGAAGTTTCCT
Duet-rev AGCCCAAAGAGSecretion of growth hormone (GH) and prolactin (PRL)
Pools of adult male or female mouse pituitaries were
used to prepare cultures as described [30]. Cells were
plated at a density of 1.5 pituitaries per well in a protam-
ine coated 96 well plate. Primary cells that had been
maintained in culture for 2–3 days were pre-rinsed 2–3
times (15–30 min each) with secretion medium
(complete serum-free medium [CSFM] containing 0.2
mg/ml BSA). To measure basal secretion cells were fed
with secretion medium for 30 min and the fraction was
collected. Following the basal collection, secretagogue
stimulated secretion was initiated by adding medium
containing 2 mM BaCl2 and/or 1 μM phorbol myristate
acetate (PMA) for 30 min. Cells were harvested at the
end of the secretion paradigm. Spent media (16% of
sample) and cell lysates (1.6% of sample) were subjected
to SDS-PAGE and western blot analysis using antibodies
to GH (JH89) [31] or PRL (IC-5, National Hormone and
Peptide Program [NIDDK, National Institutes of
Health]); cell content of hormone was normalized to γ-
adaptin (BD Transduction Laboratories).
Visualization of neuromuscular junctions and muscle
fine structure
Light microscopy
Nicotinic acetylcholine receptors (AChRs) were visua-
lized in tibialis and diaphragm muscle using α-bungaro-
toxin-tetramethylrhodamine (Sigma-Aldrich, St. Louis,
MO) as described [32]. Images were coded and neuro-
muscular junctions in tibialis muscle were categorized as
normal (pretzel-shaped) or open (broken-pretzel). Our
categorization was based on the criteria used to distin-
guish mature neuromuscular junctions from immature
(plaque-shaped and partially differentiated) junctions
[32]; each neuromuscular junction photographed en face
was categorized as “normal” or “open” based on the
number of discontinuities observed in its pretzel-like
structure; we did not observe immature junctions in the
adult tissue examined.
Electron microscopy
Animals were perfused transcardially with 4% paraformal-
dehyde (in 0.1 M sodium phosphate buffer, pH 7.4) under
deep anesthesia with ketamine/xylazine. After fixation, the
diaphragm was dissected out and placed into 4% parafor-
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bungarotoxin (100nM) at 4°C overnight. Neuromuscular
junctions (NMJ) were identified under a fluorescence
microscope and areas with NMJ’s were dissected out as
2mm cubes and processed for electron microscopy. The
small cubes were further fixed with 2.5% glutaraldehyde in
0.1M sodium cacodylate buffer, pH 7.2 at 4°C. The follow-
ing day, tissue was rinsed with cacodylate buffer and
postfixed in 1% osmium tetroxide, 0.8% potassium
ferricyanide in 0.1M cacodylate buffer for 1h at room
temperature. Following standard procedures for dehydra-
tion, the tissues were embedded in Spurr resin. Ultrasec-
tions contrasted with uranylacetate were viewed on a
Hitachi H-7650 transmission electron microscope and
photographed. Coded images of neuromuscular junctions
and muscle were scored by a blinded observer. Neuro-
muscular junctions with well defined boundaries contain-
ing neurotransmitter vesicles were considered for analysis.
The number of neuromuscular junction folds per length
of junction was measured using MetaMorph. The length
of the sarcomere, A-band, I-band and Z-band was mea-
sured using MetaMorph. Data were obtained from three
mice of each genotype.
Statistical analyses
Data are presented as average ± SEM. Statistical analyses
were performed with GraphPad Prism 4.0 (GraphPad
Software, Inc., San Diego, CA, USA) or SPSS software.
Data were analyzed using a t-test or one-way ANOVA
with Bonferrroni correction as appropriate. Two-way
repeated measures ANOVA was used to analyze the
interaction between genotype and time in the open field
or genotype and prepulse inhibition in the PPI test.
Ethics statement
Consistent with granting approval, the respective UCHC
committees (Institutional Animal Care and Use Com-
mittee; Safety) assessed the protocol to ensure the hu-
mane use and ethical care of vertebrate animals and the
safety of employees. The UCHC Office of Compliance
has rigorous policies and a well-established process for
vetting actual or potential conflicts of interest. Prior to
accepting a grant award, the Office of Research and
Sponsored Programs, which serves as the institutional
office responsible for submission of applications and ad-
ministration of awards, coordinates and verifies that all
proposed research has been approved by the committee
having jurisdiction over the matter.
Results
Kalirin is expressed within and outside of the
nervous system
Although most studies exploring Kalirin function have
focused on its roles in the nervous system, its expressionin skeletal muscle, liver and pituitary has been well
documented [11,20,30,33]. We used several primer sets
to compare Kalrn isoform expression in cortex, skeletal
muscle, pituitary, liver and aorta in adult C57BL/6 mice
using qPCR (Figure 1B). Cortex exhibited the expected
pattern, with high expression of Kalrn isoforms that in-
clude all or part of the spectrin repeat region and the
exon unique to Kalirin7. Expression of Kalirin7 was
barely detectable outside of the nervous system.
Expression of Kalrn isoforms amplified by primers
within the unique Kalirin9 30-untranslated region
(Figure 1B) or the GEF2 domain (not shown) was prom-
inent in pituitary, liver and aorta, which also contained
high levels of Kalrn transcripts that included all or part
of the spectrin repeat region. Adult skeletal muscle
expressed Kalrn transcripts amplified by Kalirin9 pri-
mers. Transcripts encoding Kalrn isoforms that could
include the Sec14p domain (KalSpec primers) were not-
ably absent from skeletal muscle and liver. Northern blot
analysis using probes specific for GEF2 and Kalirin9
revealed the presence of 2.5 and 3.3 kb transcripts that
could encode ΔKalirin9 and Kal Duet9 (Figure 1A) in
liver polyA+ RNA (Figure 1C). The interaction of Kalirin
with a secretory granule enzyme and the locomotor role
of the C.elegans orthologue of Kalrn led us to include
evaluations of pituitary and muscle function in our
examination of the KalSRKO/KO mouse.
Generation and validation of KalSRKO/KO mice
We targeted exon 13 of the Kalrn gene for elimination
because splicing of exon 12 to any of the subsequent fif-
teen exons would yield an out-of-reading frame product.
The strategy for eliminating exon 13 is outlined in
Figure 2A [13]. As shown in Figure 2B, PCR analysis
enabled monitoring of all of the expected genotypes
from ear punches gathered when identifying weanlings.
All PCR products were verified by DNA sequencing.
KalSRCKO/CKO mice were indistinguishable from wild-
type C57BL/6 mice. Exon 13 was removed by breeding
KalSRCKO/+ males with Hprt-Cre females; these mice
lack 2.25 kb of chromosome 16 and retain one Lox-p
sequence.
KalSRKO/KO mice were generated by mating KalSR+/KO
mice and were viable. Western blot analysis using an
antibody specific for the spectrin-repeat region of Kalirin
confirmed the loss of Kalirin7, 9 and 12 from homoge-
nates of adult cortex (Figure 2C). A cross-reactive pro-
tein slightly smaller than ΔKalirin7 was detected in the
KalSRKO/KO sample (Figure 2C; #). To determine its
identity, transcripts initiated from the Δ-promoter
were cloned and sequenced using cortical mRNA from
KalSR+/KO mice. Based on this analysis, the band indi-
cated by # could be encoded by transcripts initiated
from the Δ-promoter and lacking exon 13. Stop codons
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but a 107 kDa protein lacking the first 139 residues of
ΔKalirin7, replaced by 67 residues in a different reading
frame, could be produced by translation that started
at the sixth AUG. To test this hypothesis, a Kalirin7-
specific antibody was used to analyze PSDs prepared
from wildtype and KalSRKO/KO cortex (Figure 2D); pro-
teins the size of Kalirin7 and ΔKalirin7 were absent from
the KalSRKO/KO samples and a single product of the pre-
dicted mass was apparent. Use of an antibody specific
for the region unique to Kalirin12 confirmed its loss
from both the soluble and PSD-enriched fractions of
adult cortex (Figure 2E).
We used qPCR to verify the elimination of transcripts
containing Kalrn exon 13 and to evaluate expression of
transcripts initiated at the Kalrn Duet promoter, which is
located in the intron preceding exon 35 (Figure 2A). As
expected, exon 13-containing transcripts were eliminated
in all tissues examined (Figure 2F). Transcripts initiated at
the Duet promoter were not eliminated and were presentFigure 3 Kalirin Exon 13 knockout results in growth retardation. A. Af
and females yielded WT, KalSRKO/+ and KalSRKO/KO progeny in a Mendelian
at regular intervals. Male (B) KalSRKO/KO mice grew more slowly than WT m
the same rate as WT mice. Neither male nor female KalSRKO/KO mice grewin cortex, skeletal muscle and pituitary. KalSRKO/KO mice
lack Kalrn transcripts initiated at five of the six major
Kalrn promoters. The consensus for nonsense-mediated
decay is that mRNAs are targeted for destruction when
translating ribosomes encounter a stop codon followed
within a short distance by a downstream splice site [34-36].
For Kalirin transcripts initiated at the full-length Sec14-
promoters, the first stop codon produced by splicing exon
12 to exon 14 is not followed closely by a splice site; since
these transcripts might not be subject to nonsense-
mediated decay, it was expected that qPCR for the Kalirin
Spectrin region (from Exon 10 to Exon 11) could yield nor-
mal levels in KalSRKO/KO mice.
KalSRKO/KO mice show deficits at parturition
Once bred more than 10 generations into the C57Bl/6
background, the yield of pups from KalSR+/KO matings
matched the expected Mendelian 1:2:1 ratio (Figure 3A).
Earlier in the process of breeding from a mixed 129/C57
background, the yield of KalSRKO/KO pups was lower, aster breeding into a C57BL/6 background, matings of KalSRKO/+ males
ratio. B and C. After weaning, WT and KalSRKO/KO mice were weighed
ice. Female (C) KalSRKO/KO mice were smaller at weaning but grew at
in a manner identical to WT mice (p<0.0002).
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male KalSRKO/KO mice carried litters to term, most could
not give birth and died during parturition, in spite of oxy-
tocin administration. KalSRKO/KO dams that gave birth
showed deficits in nesting, pup rearing and milk letdown.
Weight data for WT and KalSRKO/KO littermates were
collected from weaning up to 2 years of age (Figure 3 B,
C). A repeated measures general linear mixed model
(GLMM) was used to analyze the growth curves using the
MIXED procedure in SAS (SAS Institute Inc, Cary, NC)
[37]. In these models the unit of analysis is the mouse and
each mouse contributes a set of weights over time. A com-
pound symmetry covariance structure was fit. We tested
for equality of intercepts (weight at weaning) and slopes
(growth rate) for the WT and KalSRKO/KO mice. Male
KalSRKO/KO mice were not significantly smaller than WT
mice at weaning (p=0.15) but grew at a slower rate, never
attaining the normal growth curve (p<0.0002) (Figure 3B).
Female KalSRKO/KO mice were smaller than WT mice at
weaning (p=0.003), grew at a similar rate (p=0.81) but
never attained the normal growth curve (p<0.0002) [37]
(Figure 3C).
Cultured pituitary cells reveal cell autonomous deficits in
basal secretion in KalSRKO/KO
Kalirin is known to play a pivotal role in secretory gran-
ule maturation and storage [30]. Given these previousFigure 4 KalSRKO/KO anterior pituitary cultures showed elevated basa
pituitary cells from male or female WT and KalSRKO/KO mice were fed with
medium and medium containing 1 μM PMA. Cell lysates (1.67% of the tota
growth hormone and prolactin; representative blots are shown. Secretion r
medium as a percentage of the total amount of hormone in the cells at th
rate of secretion was subtracted from the total rate of secretion in the pres
rates were observed, data for male and female cultures were averaged. Bas
KalSRKO/KO mice (growth hormone t(4)= 3.26, p<0.05; prolactin t(6)=4, p<0.findings and the deficits in growth (Figure 3) and lacta-
tion, we used primary cultures to examine pituitary hor-
mone secretion in KalSRKO/KO mice. Although anterior
pituitary somatotropes from KalSRKO/KO mice synthe-
sized and stored growth hormone normally, basal secre-
tion of growth hormone (expressed as the percentage of
cell content secreted per hour) was elevated compared
to WT (t-test, p<0.05). In contrast, stimulation of secre-
tion over basal levels by BaCl2 or phorbol myristate acet-
ate was unaltered (Figure 4). Normal growth depends on
pulsatile release of growth hormone [38], which reflects
both hypothalamic input and nutrient feedback; any dis-
ruption in the normal pattern could contribute to defi-
cient growth.
Prolactin secretion showed a similar genotypic differ-
ence, with increased basal secretion by KalSRKO/KO lac-
totropes; since lactotropes in vivo are subject to tonic
inhibition by dopamine, basal secretion of PRL in cell
culture is substantially higher than basal secretion of
GH. KalSRKO/KO and wildtype lactotropes did not differ
in their ability to increase prolactin secretion over basal
levels in response to BaCl2 or PMA (Figure 4).
Similarities in blood pressure, ability to respond to stress
and basal locomotor activity in WT and KalSRKO/KO mice
Since Kalirin has been implicated in early onset cardiovas-
cular disease [39], resting blood pressure was evaluated inl secretion of growth hormone and prolactin. Cultured anterior
basal medium followed by medium containing 2 mM BaCl2 , basal
l) and media (16.7% of the total) were probed by immunoblotting for
ates were calculated by expressing the amount of hormone in the
e end of the experiment; for the BaCl2 and PMA samples, the basal
ence of secretagogue. Since no sex-specific differences in secretion
al growth hormone and prolactin secretion were increased in
05); error bars are S.E.M.
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observed in this parameter, but Fanaroff et al. [5] have
reported a role for Kalrn in smooth muscle cell migra-
tion/proliferation and atherogenesis (Figure 5A).
Our earlier work on the role of Kalrn in pituitary cells,
deficits in peptidergic secretion in C. elegans expressing
UNC-73 mutants and deficits in basal growth hormone
and prolactin secretion by pituitary cells lacking Kalrn
suggested that there might be widespread alterations in
peptidergic secretion in KalSRKO/KO mice. To evaluate
this possibility, serum levels of a widely expressed
secretory granule enzyme were monitored (Figure 5B);
serum PHM activity was identical in WT and KalSRKO/KO
mice. As another test of peptidergic function, restraint
stress was used to stimulate the hypothalamic-pituitary-
adrenal axis in KalSRKO/KO mice (Figure 5C); secretion of
both hypothalamic corticotropin releasing hormone andFigure 5 Physiological and behavioral similarities between KalSRKO/KO
using the tail-cuff method (CODA-2, Kent Scientific, Torrington, CT). Mice w
made. Each measurement consisted of 5 acclimatization cycles followed by
differ and were pooled. There were no significant differences in the BP of W
female mice collected under basal conditions or after restraint stress (15 m
differ and no significant differences were found between WT and KalSRKO/K
measured in male and female mice under basal conditions and after a 15 m
separately. No significant differences were found between genotypes; error
and females behaved similarly) showed time dependent decreases in spon
significant difference between genotypes over the 45 min test.pituitary adrenocorticotropic hormone is required for a
normal response. Neither basal levels of corticosterone
nor the ability to secrete corticosterone in response to
stress was altered in male or female KalSRKO/KO mice; as
expected, corticosterone levels rose higher in female than
in male mice after restraint stress (Figure 5C) [40].
Since many of the behavioral tests to be conducted
rely on locomotor activity, we evaluated spontaneous
locomotor activity in an open field chamber for 45 min;
there were no significant differences between WT and
KalSRKO/KO mice (Figure 5D).
Behavioral analysis of KalSRKO/KO mice
KALRN has been genetically associated with several
neuropsychiatric disorders; therefore a battery of behav-
ioral tests was carried out on WT and KalSRKO/KO mice.
Since Kalirin7 is also absent in KalSRKO/KO mice, we firstand WT mice. A. Blood pressure was measured in conscious animals
ere trained for three days and on the fourth day BP recordings were
15 BP measurements cycles; data for male and female mice did not
T and KalSRKO/KO mice; error bars are S.E.M. B. Sera from male and
in) were subjected to PHM assay. Data for males and females did not
O mice; error bars are S.E.M. C. Serum corticosterone levels were
in restraint stress; data for male and female mice are shown
bars are S.E.M. D. In the open field, WT and KalSRKO/KO mice (males
taneous locomotor activity (F(8,208)=32.91 p<0.001), with no
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WT, KalSRKO/+ and KalSRKO/KO mice were evaluated in
the elevated zero maze; there was a clear effect of geno-
type on time spent in the open area, indicating a decrease
in anxiety-like behavior (Figure 6A). KalSRKO/KO mice
spent a significantly longer time in the open area of the
elevated zero maze than WT mice (Figure 6A). KalSR+/KO
mice did not differ significantly from WT or KalSRKO/KO
mice (Figure 6A).
Since KALRN transcript and Kalirin protein levels were
reduced in hippocampi collected from Alzheimers
patients [41], we wanted to test KalSRKO/KO mice in hip-
pocampal dependent tasks. Passive avoidance condition-
ing tests hippocampus-dependent memory [13]. During
the training session, WT, KalSR+/KO and KalSRKO/KO mice
showed the same latency to cross to the dark side of the
chamber (Figure 6B). When tested 24 h after receiving a
single foot shock, it was clear that genotype had aFigure 6 KalSRKO/KO mice exhibit several behavioral changes similar t
maze test for 5 min. KalSRKO/KO mice spent more time in the open arm tha
dependent impairment was evident in the passive avoidance test, with the
Bonferroni corrected t-tests revealed a difference between WT and KalSRKO
C. A novel object recognition paradigm was used to determine learning an
KalSRKO/KO mice spent significantly more time with the novel object (WT, t(
showed increased exploratory behavior compared to WT mice (t(28)=4.519
similarly in elevated zero maze and passive avoidance tests and data were
male mice.significant effect on the response. KalSRKO/KO mice exhib-
ited a significantly decreased latency to cross to the foot
shock-paired side relative to WT mice. Once again, the
KalSR+/KO mice exhibited a response intermediate to that
of WTand KalSRKO/KO mice.
Kal7KO/KO mice performed normally in the radial arm
maze and in tests of novel object recognition [13].
KalSRKO/KO mice spent significantly more time explor-
ing both objects on the pretest day than did WT mice
(Figure 6C). The total time spent exploring objects was
also significantly higher for KalSRKO/KO mice on the test
day, but KalSRKO/KO mice recognized the novel object as
well as WT mice (Figure 6C). The increased object ex-
ploration observed in KalSRKO/KO mice may reflect their
decreased anxiety-like behavior or may reflect impaired
response habituation [42] (Figure 6A).
Additional tests were used to evaluate the behavior of
the KalSRKO/KO mice. Depression-like behavior waso Kal7KO/KO mice. A. Naive mice were subjected to the elevated zero
n WT mice (F(2,35)=9.926, p<0.001); error bars are S.E.M. B. Genotype
greatest effect on KalSRKO/KO mice (F(2,42)= 9.658; p<0.001).
/+ (p<0.05) mice but not between KalSR+/KO and KalSRKO/KO mice.
d memory impairments in the KalSRKO/KO mice. Both WT and
28)=8, p<0.001)(KO, t(28)=5.5, p<0.001), but KalSRKO/KO mice
,p<0.05 ); error bars are S.E.M. Male and female mice responded
pooled; the novel object recognition test was carried out only on
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There was no difference in immobility time for WT and
KalSRKO/KO mice.
Prepulse inhibition is the decrease in startle response
to an intense auditory stimulus that is preceded by a
smaller auditory prepulse [43]. Decreased KALRN
mRNA levels were reported in the prefrontal cortex of
subjects with schizophrenia [7,44], and PPI deficits due
to altered sensory motor gating have been reported in
schizophrenic patients and psychosis-prone individuals
[45]. The startle response to pulse-alone trials in
KalSRKO/KO mice was significantly lower than in WT
mice (Figure 7B). Contrary to our expectations, there was
no significant difference between WT and KalSRKO/KO
mice in the prepulse induced inhibition of acoustic startle.
However, the diminished startle response observed in the
KalSRKO/KO suggested a role for altered neuromuscular
function, which was examined directly.
KalSRKO/KO and KalSR+/KO mice show deficits in
neuromuscular function
Motor coordination was first tested using a rotarod;
mice trained for three days were tested on the fourth
day. Both the KalSR+/KO and KalSRKO/KO mice showed a
decreased ability to perform this task relative to WT
mice (Figure 8A); KalSRKO/KO mice were more affected
than KalSRKO/+ mice. Skeletal muscle function was fur-
ther probed using a wire hang test. KalSR+/KO and
KalSRKO/KO mice showed a drastic reduction in their
ability to suspend themselves from a wire compared to
WT mice (Figure 8B).
Since Kalrn is expressed in both motor neurons and
skeletal muscle, the phenotype observed could resultFigure 7 KalSRKO/KO mice lack depressive-like symptoms and have no
female) showed no significant difference when subjected to tail suspension
B. Behavioral similarities exist between WT and KalSRKO/KO mice in the prep
and significant prepulse inhibition (left y-axis) at all intensities (F (4,56)=61.2
decreased startle response (right y-axis) compared to WT mice (t (14)=2.26;from the loss of Kalrn expression in either or both cell
types. In order to direct elimination of Kalrn expression
to the nervous system, KalSRCKO/CKO mice were mated
with nestin-Cre mice [46]. In these mice Cre is broadly
expressed throughout the central nervous system from
early embryonic development through adulthood;
restricted expression is also observed in the vasculature
and scattered cells in a wide variety of tissues (http://
jaxmice.jax.org/strain/003771.html). KalSRNesKO/NesKO
and control KalSRCKO/CKO mice were evaluated in the
rotarod and wire hang tests. Since Kal7KO/KO mice would
be expected to mimic neuron-specific elimination of
Kalrn expression, they were evaluated using the same
tests. Compared to KalSRKO/KO mice, KalSRNesKO/NesKO
mice exhibited less of a decrease in their ability to remain
on the rotarod (Figure 8C); the performance of Kal7KO/KO
mice did not differ from that of WT mice in this test. In
the wire hang test, KalSRNesKO/NesKO mice were
indistinguishable from the KalSRCKO/CKO controls and did
not exhibit the profoundly impaired performance
observed in KalSRKO/KO mice (Figure 8D); Kal7KO/KO
mice remained suspended from the wire for a longer time
than WT mice.
KalSRKO/KO mice show deficits in neuromuscular junction
and muscle structure
In order to evaluate the structure of the neuromuscular
junction, tibialis muscles from KalSRKO/KO and WT
mice were visualized after binding fluorescently tagged
bungarotoxin to the nicotinic aceylcholine receptor
(Figure 9A). The expected compact, pretzel-like struc-
tures were consistently observed in WT muscle while a
more open, less well organized pattern was common inrmal sensorimotor gating. A. WT and KalSRKO/KO mice (male and
, to determine depressive-like behavior (t(16)=0.36; p>0.05).
ulse inhibition test; male mice of both genotypes showed a similar
7 p<0.001). In the pulse alone trials, KalSRKO/KO mice showed a
p<0.05); error bars are S.E.M.
Figure 8 KalSRKO/KO mice show loss of muscle strength, coordination and stamina. A. After three training days, male and female mice were
placed onto an accelerating rotarod, and time to fall from the rotarod was recorded for 3 successive trials separated by 20 min. KalSRKO/KO mice
stayed on the rotarod for less time than WT or Kal+/KO mice (F(2,35)=39.68: p<0.0001). Bonferroni corrected t-tests revealed a significant difference
between all genotypes. B. In the wire hang test, both KalSRKO/KO and KalSR+/KO mice spent less time suspended than WT mice (F(2,32)=35.42,
P<0.001). C. In the rotarod test, the performance of KalNesKO/NesKO mice was impaired compared to control KalSRCKO/CKO mice (p<0.01). Kal7KO/KO
mice showed no impairment compared to WT controls. D. In the wire hang test, KalNesKO/NesKO mice and control KalSRCKO/CKO mice spent equal
amounts of time suspended. Kal7KO/KO mice spent more time suspended than WT mice (p<0.01). Data for male and female mice were combined
for the rotarod and wire hang tests.
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criteria [32] suggested a significant difference in the
organization of the nicotinic acetylcholine receptors at
the neuromuscular junction in KalSRKO/KO mice
(Figure 9B).
For a more detailed, quantitative analysis, we turned
to the diaphragm muscle; neuromuscular junctions were
localized in fixed tissue and analyzed by transmission
electron microscopy. In both WT and KalSRKO/KO mice,
muscle fibers were well organized (Figure 10A,B), with
peripheral nuclei and normal mitochondrial content.
Sarcomere length was increased in KalSRKO/KO mice,
reflecting an increase in I-band length; A-band length
was unaltered (Figure 10E). Z-line thickness was
decreased in KalSRKO/KO muscle.Neuromuscular junctions were identified based on the
apposition of specialized regions of muscle membrane
and nerve endings filled with synaptic vesicles and mito-
chondria [47]. Well organized junctional folds closely
apposed to nerve terminals filled with synaptic vesicles
were readily found in WT tissue (Figure 10C). In con-
trast, both the nerve terminals and junctional folds were
disturbed in KalSRKO/KO mice (Figure 10D). The num-
ber of junctional folds/μm of synaptic membrane was
quantified by a blinded observer and was decreased in
the KalSRKO/KO mice (Figure 10F). In addition, mito-
chondria often accumulated in the presynaptic endings
of KalSRKO/KO mice. Differences in both neuronal and
muscle tissue may contribute to the altered rotarod and
wire hang performance.
Figure 9 Neuromuscular junctions are abnormal in KalSRKO/KO mice. A. Individually teased fixed anterior tibialis muscles of adult WT and
KalSRKO/KO male and female mice were incubated with fluorescently tagged α-BTX to visualize postsynaptic AChR clusters. B. Neuromuscular
junctions were categorized as normal (pretzel-shaped) or open (broken) and the percentage of the junctions categorized as normal was
calculated for three WT and three KalSRKO/KO mice; bars show data from a single mouse. KalSRKO/KO mice have a lower fraction of intact pretzel
shaped junctions (t-test; p=0.044) and a larger fraction of broken junction shapes (t-test; p=0.044).
Figure 10 KalSRKO/KO mice have abnormal skeletal muscle ultrastructure. Diaphragm muscle from WT and KalSRKO/KO male and female mice
was prepared for electron microscopic analysis. Representative images showing alterations in muscle (A,B) and neuromuscular junction (C,D)
architecture are shown. A sarcomere, with the A, I and Z bands marked, is shown in (A). E. KalSRKO/KO mice showed increased sarcomere (t(4)=12,
p<0.001), increased I-band (t(4)=19,p<0.001) and decreased Z-band (t(4)=12,p<0.01) length. F. Junctional folds, shown schematically, were
quantified per μm of junctional membrane; KalSRKO/KO mice showed a decrease in junctional fold density (t(4)=4 p<0.05).
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Genetic linkage studies and analyses of post-mortem
tissue have associated human KALRN with a wide
array of neuropsychiatric and cardiovascular diseases
[6,7,10,24,25,39,48]. Detailed studies of the actions of
Kalirin7, the major isoform in the adult nervous sys-
tem, identified several pathways through which Kalirin7
can participate in spine formation and synaptic plasti-
city [13,17,18,49-51], but have not provided insight into
the roles played by other Kalirin isoforms within or
outside of the nervous system. Analysis of the C. ele-
gans and D. melanogaster ortholog of Kalrn revealed
essential roles for this gene both within and outside of
the nervous system [52-55]; neither species has an iso-
form similar to Kalirin7.Functions unique to Kalirin9 and Kalirin12
Kalirin9 and Kalirin12 are expressed in skeletal muscle,
pituitary, liver and aorta, but very little Kalirin7 is
expressed outside of the nervous system. The second
GEF domain of Kalrn, which is present in Kalirin9 and
Kalirin12, but absent from Kalirin7, activates RhoA, not
Rac1 or RhoG. The downstream effectors of Rac1 and
RhoA are distinctly different [1,56,57] and many of the
disease-associated mutations identified in human
KALRN map near the second GEF domain [6]. In the fly
and worm orthologs of Kalrn, the Rac- and Rho-
specific GEF domains play different but essential roles
[52-54]. This strongly suggests unique roles for the
Kalrn isoforms that contain the Rho-specific GEF2 do-
main. The GEF2 domain of UNC-73 plays a role in
muscle contraction triggered through G protein
coupled receptors signaling through Gαq [22]. Struc-
tural analysis of a Gαq-p63RhoGEF-RhoA complex
indicates that Gαq relieves the autoinhibitory effect of
the PH domain; Gαq also activates the GEF2 domain
of Kalrn [58]. Interactions unique to Kalirin12 have
also been identified [59]; the binding of dynamin to
the Ig/Fn domain is consistent with a role for Kalrn in
endocytosis [60]. The fly and worm orthologs of Kalrn
lack a kinase domain and offer no insight into its po-
tential roles.
By comparing the phenotypes of the different Kalrn
knockout mouse lines, we identified deficits caused by
the loss of all of the Kalirin isoforms that were not
observed in mice lacking only Kalirin7. Deficits observed
in the KalSRKO/KO mice but not in the Kal7KO/KO mice
presumably reflect the functions of Kalirin9 and −12
both within and outside of the nervous system. Deficits
common to KalSRKO/KO and Kal7KO/KO mice reflect sites
at which Kalirin7 is expressed and its unique localization
to the PSD, where it can interact with PDZ domain con-
taining proteins.Deficits unique to KalSRKO/KO mice
One of the most striking deficits unique to KalSRKO/KO
mice was their inability to perform in the rotarod and
wire hang tests. That KalSR+/KO heterozygote mice also
failed to perform normally in either test suggests that
motor deficits are a sensitive indicator of compromised
Kalrn function. Examination of the neuromuscular junc-
tion in KalSRKO/KO mice revealed deficits in both the
muscle and the presynaptic ending. A role for Kalrn in
muscle is consistent with findings in C. elegans [22].
Splice variants of UNC-73 that resemble Kal Duet 9, a
mammalian isoform generated from the Duet promoter,
play essential roles in pharynx and vulval muscle [22]. In
mammals, the Duet promoter also yields Kal Duet 12,
which contains both a GEF domain and an active kinase
domain [33].
The extensive signaling that occurs between skeletal
muscle and the innervating motor neuron means that
further experiments will be required to distinguish the
roles of the different Kalrn isoforms in these two tissues.
Kalirin9 and Kalirin12 are the most prevalent isoforms
in the brain during embryonic development, and ex-
ogenous Kalirin9 or Kalirin12 in superior cervical gan-
glion neurons stimulated the initiation, growth and
branching of axons [61]. Kalirin9 and Kalirin12 decline
when Kalirin7 expression increases during the burst of
synaptogenesis that occurs after birth [16]. Kalirin9, but
not Kalirin7 or Kalirin12, binds p75 and regulates p75-
Nogo receptor-dependent RhoA activation in cerebellar
granule neurons in culture, inhibiting myelin formation
[62]. In Drosophila, dTrio interacts with Notch, affecting
axon sprouting and guidance [63]; the GEF1 domain,
but not the GEF2 domain, is essential for this interaction
[23]. dTrio expressed in neurons is also a key compo-
nent of the BMP retrograde signaling pathway used to
coordinate pre- and post-synaptic development of the
neuromuscular junction [55].
KalSRNesKO/NesKO mice, which lack all isoforms of
Kalrn in the nervous system, exhibited a deficit in
rotarod behavior but were not impaired to the same ex-
tent as KalSRKO/KO mice; Kal7KO/KO mice behaved like
WT mice. Thus it is clear that isoforms of Kalrn
expressed outside of the nervous system play an essen-
tial role in rotarod performance. Since Kalirin9 and
Kalirin12 are expressed in skeletal muscle, the deficit
may be a direct result of their absence from muscle cells.
A better understanding of the role of Kalirin in skeletal
muscle requires identifying the sites at which it is
located. The clustering of receptors, ion channels and
signaling proteins that occurs at the neuromuscular
junction involves proteins similar to those involved in
the formation of the PSD and skeletal muscle Kalirin
could play a role in this process. The effect of Kalirin on
the Z-line could be direct or indirect; many of the same
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ticipate in Z-line formation. The increase in sarcomere
length observed in KalSRKO/KO diaphragm muscle arose
from an increase in the length of the I-band, which con-
sists of actin filaments whose pointed ends extend be-
tween the myosin filaments. The barbed ends of the
anti-parallel actin filaments from adjacent sarcomeres
meet at the Z-line, which showed a decrease in width in
KalSRKO/KO mice. Z-line width is thought to correlate
with the layers of α-actinin that cross-link the anti-
parallel actin filaments [64]. α-Actinin, which binds to
NMDA receptors, is enriched at the PSD; when over-
expressed in hippocampal neurons, α-actinin increases
the formation of long dendritic protrusions [65].
While loss of Kalirin expression in skeletal muscle
may contribute to the inability of KalSRKO/KO mice to
perform in the wire hang test, it is clear that expression
of Kalirin7 in the nervous system also plays an import-
ant role in this behavioral response. Kal7KO/KO mice
remained suspended from the wire for a far longer time
than WT mice, suggesting that central control of skeletal
muscle has been altered. The KalSRNesKO/NesKO mice ex-
hibit a response intermediate to that of KalSRKO/KO and
Kal7KO/KO mice and similar to that of KalSRCKO/CKO
mice. The many pathways through which the CNS
controls skeletal muscle contraction make it impos-
sible to identify the sites at which Kalirin7 plays an
essential role, but it is not uncommon for mouse
mutants to show differential susceptibility to changes
in performance in the wire hang and rotarod tests
[66,67].
The novel object recognition test revealed an intri-
guing difference between KalSRKO/KO and Kal7KO/KO
mice; while KalSRKO/KO mice spent more total time ex-
ploring the objects than WT mice, Kal7KO/KO mice did
not. This difference suggests that Kalirin9 and/or
Kalirin12 contribute to this behavior. The age dependent
hyperactive behavior reported in KalGEF1KO/KO mice
[25] may be similar to the enhanced exploration of both
familiar and novel objects seen with the KalSRKO/KO
mice, and may reflect the absence of Kalirin9 and/or
Kalirin12. Due to the absence of Kalirin isoforms that in-
clude the GEF2 domain, the functioning of pathways
that rely on GPCR signaling through Gαq to RhoA may
be impaired. Both cholinergic signaling through M1, M3
and M5 muscarinic receptors [68] and serotonergic sig-
naling through 5HT2A and 5HT2C receptors involve Gαq
[69,70].
A role for Kalirin in secretory granule release was
expected from previous studies using pituitary cells in
culture [30], from the fact that Kalirin was first identified
through its interaction with a secretory granule mem-
brane protein and from the altered neurotransmitter re-
lease observed in worms and flies [22,52-55]. Theincreased basal secretion of PRL and GH observed in
KalSRKO/KO pituitary cells in culture may underlie the
growth deficits in the animal, since elevated GH without
the normal periodicity in its secretion contributes to
stunted growth in experimental animals and across the
human population [38,71,72]. Altered basal secretion of
peptides could be expected to contribute to other defi-
cits observed in KalSRKO/KO mice, especially at the
neuromuscular junction.Deficits common to KalSRKO/KO and Kal7KO/KO mice
A similar decrease in baseline anxiety-like behavior was
seen in both KalSRKO/KO and Kal7KO/KO mice. KalSRKO/KO
mice and Kal7KO/KO mice also exhibited comparably
impaired passive avoidance behavior. Since Kal7KO/KO mice
produce slightly increased amounts of Kalirin9 and
Kalirin12 compared to WT mice [13], we think it likely that
a lack of Kalirin7 causes the changes observed in the
affected pathways. It is clear that Kalirin7 plays an essential
role in the formation and function of excitatory synapses
on dendritic spines. Both NMDA receptor dependent LTP
and LTD are deficient in Kal7KO/KO mice [73]. In the
absence of Kalirin7, chronic cocaine treatment is unable
to increase the size or the number of spines on the
dendrites of medium spiny neurons in the nucleus
accumbens [24]. In hippocampal cultures, a decrease in
Kalirin7 expression both reduced the density of excita-
tory synapses and the ability of estadiol to increase
synapse formation [19].
Expression of Kalirin in the amygdala, one of the
regions that plays a critical role in anxiety-like behavior
and passive avoidance, is not notably different from ex-
pression levels elsewhere in the brain, but region or
cell-type specific differences in the expression of key
interactors may determine which pathways are most
sensitive to a decrease in Kalirin7 levels. Many of pro-
teins identified in a screen for Kalirin7 PDZ binding
motif interactors are known to be involved in the clus-
tering of NMDA and AMPA receptors (PSD-95,
SAP102, SAP97, Chapsyn-110, PICK-1) [15,49]. Other
interactors link Kalirin7 to filamentous actin (ZO-1,
ZO-2, neurabin, spinophilin, AF-6/afadin), a key deter-
minant of spine shape and thus of spine function. Of
special interest, given the role of serotoninergic trans-
mission in anxiety and fear, is MUPP1, which binds to
both Kalirin7 and to the 5HT2A and 5HT2C receptors
[15,74].
Kalirin7, Kalirin9 and Kalirin12 share the ability to
interact with a wide variety of proteins including pepti-
dylglycine α-amidating monoxygenase (PAM) [75],
DISC-1 [9], TrkB [76], inducible NOS [77], NR2B [29]
and phosphoinositides [60] through their common
Sec14, spectrin repeat and GEF1 domains.
Mandela et al. BMC Neuroscience 2012, 13:136 Page 16 of 18
http://www.biomedcentral.com/1471-2202/13/136Manipulating Kalrn to study psychiatric/
neurological disorders
KALRN has been linked to schizophrenia and adult
ADHD, and mouse models for these diseases would be
of great use. Patients suffering from a variety of neuro-
psychiatric disorders including schizophrenia, obsessive
compulsive disorder and Huntington’s disease often ex-
hibit deficits in prepulse inhibition [45,78,79]. The link-
age of KALRN to schizophrenia and the interaction of
Kalirin with DISC-1 made prepulse inhibition, which
can be modeled in rodents [45], of particular interest.
However, in a test of prepulse inhibition of acoustic star-
tle, KalSRKO/KO mice showed no sensorimotor deficits;
KalSRKO/KO mice evinced a decreased startle response in
the pulse alone trials, demonstrating deficits in their
baseline startle response. While KalGEF1KO/KO mice
showed reduced prepulse inhibition of acoustic startle
relative to WT mice [25], neither the WT nor the Kal-
GEF1KO/KO mice showed the expected intensity depend-
ence of prepulse induced inhibition [25]. The fact that
both WT and KalSRKO/KO mice showed a graded in-
crease in inhibition of acoustic startle with increasing
prepulse intensity supports the conclusion that ablation
of Kalrn did not result in a hearing or response deficit.
Several studies have noted significant co-morbidity of
neuromuscular deficits and schizophrenia [80-82], which
might be associated with deficits in KALRN.
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